Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11680802 | 0.88 | IDO1 (0.42) | SIGMAR1KDM1AMAOAMAOBIDO1 | |
| SCHEMBL17373052 | 0.78 | SCN4A (0.50) | HTR2AHRH1 | |
| SCHEMBL9009370 | 0.78 | METAP2 (0.46) | IDO1 | |
| SCHEMBL28660567 | 0.78 | METAP2 (0.46) | IDO1 | |
| SCHEMBL12927229 | 0.78 | METAP2 (0.46) | IDO1 | |
| SCHEMBL28672429 | 0.78 | METAP2 (0.46) | IDO1 | |
| SCHEMBL7898573 | 0.78 | METAP2 (0.46) | IDO1 | |
| SCHEMBL6570842 | 0.77 | CYP2D6 (0.47) | SIGMAR1KDM1AMAOAMAOBIDO1 | |
| Hydrochloric Acid SCHEMBL28350804 | 0.76 | SCN4A (0.48) | HTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL9009360 | 0.76 | IDO1 (0.46) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3509116-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR BATTERY | FUJIFILM Corporation (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190189944-A1 | PHOTOELECTRIC CONVERSION ELEMENTS AND SOLAR CELL | FUJIFILM CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190189944-A1 | PHOTOELECTRIC CONVERSION ELEMENTS AND SOLAR CELL | NR2E3, SCN3A, CRY1 | SIGMAR1 2360/4885NPSR1 1252/4885KDM1A 1654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.